Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levesque

Showing results (211-220 of 281) with videos related to

Pageof 29
Sort By:
Scientific Reports|July 19, 2016
Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophagesRoman Huber, Barbara Meier, Atsushi Otsuka, et al.
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Communications Biology|October 28, 2022
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseqGaetana Restivo, Aizhan Tastanova, Zsolt Balázs, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cellsMi He, Bhavesh Soni, Petra C Schwalie, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Cell|March 16, 2016
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma TherapyMichael P Smith, Holly Brunton, Emily J Rowling, et al.
Leukemia|April 30, 2015
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AMLC E Forristal, A L Brown, F M Helwani, et al.
Cancer Research|October 14, 2021
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma ProgressionAnnalisa Saltari, Andreas Dzung, Marika Quadri, et al.
Molecular Systems Biology|August 21, 2023
Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channelMarvin Thielert, Ericka Cm Itang, Constantin Ammar, et al.
Frontiers in Cell and Developmental Biology|May 16, 2022
An Optimized Tissue Dissociation Protocol for Single-Cell RNA Sequencing Analysis of Fresh and Cultured Human Skin BiopsiesBlaž Burja, Dominique Paul, Aizhan Tastanova, et al.
Pageof 29

Showing results (211-220 of 281) with videos related to

Sort By:
Pageof 29
Scientific Reports|July 19, 2016
Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophagesRoman Huber, Barbara Meier, Atsushi Otsuka, et al.
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Communications Biology|October 28, 2022
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseqGaetana Restivo, Aizhan Tastanova, Zsolt Balázs, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cellsMi He, Bhavesh Soni, Petra C Schwalie, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Cell|March 16, 2016
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma TherapyMichael P Smith, Holly Brunton, Emily J Rowling, et al.
Leukemia|April 30, 2015
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AMLC E Forristal, A L Brown, F M Helwani, et al.
Cancer Research|October 14, 2021
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma ProgressionAnnalisa Saltari, Andreas Dzung, Marika Quadri, et al.
Molecular Systems Biology|August 21, 2023
Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channelMarvin Thielert, Ericka Cm Itang, Constantin Ammar, et al.
Frontiers in Cell and Developmental Biology|May 16, 2022
An Optimized Tissue Dissociation Protocol for Single-Cell RNA Sequencing Analysis of Fresh and Cultured Human Skin BiopsiesBlaž Burja, Dominique Paul, Aizhan Tastanova, et al.
Pageof 29